High-Dose Cyclophosphamide Administration Orchestrates Phenotypic and Functional Alterations of Immature Dendritic Cells and Regulates Th Cell Polarization-Reference-Cited by-同舟云学术

High-Dose Cyclophosphamide Administration Orchestrates Phenotypic and Functional Alterations of Immature Dendritic Cells and Regulates Th Cell Polarization

Published:2020-05-25 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Bao Lei,Hao Changfu,Wang Juan,Wang Di,Zhao Youliang,Li Yiping,Yao Wu

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference45 articles.

1. Activation of MAP kinase p38 is critical for the cell-cycle-controlled suppressor function of regulatory T cells;Adler;Blood,2007

2. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos;Agrawal;J. Immunol. (Baltimore Md. : 1950),2003

3. The effects of daily cyclophosphamide administration on the development and extent of primary experimental interstitial nephritis in rats;Agus;Kidney Int.,1986

4. Membrane-organizing protein moesin controls Treg differentiation and antitumor immunity via TGF-beta signaling;Ansa-Addo;J. Clin. Invest.,2017

5. Modulation of p38 MAPK signaling enhances dendritic cell activation of human CD4+ Th17 responses to ovarian tumor antigen;Cannon;Cancer Immunol. Immunother.,2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infections associated with CAR‐T cell therapy in patients with relapsed refractory multiple myeloma: Risks and prevention strategies;Cancer Medicine;2024-06

2. A real‐world observation on thrombopoietic agents for patients with cancer treatment–induced thrombocytopenia in China: A multicenter, cross‐sectional study;Cancer;2024-03-22

3. Cucurbitacin IIa promotes the immunogenic cell death‑inducing effect of doxorubicin and modulates immune microenvironment in liver cancer;International Journal of Oncology;2024-02-20

4. Lactoferricin B Combined with Antibiotics Exhibits Leukemic Selectivity and Antimicrobial Activity;Molecules;2024-02-01

5. Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy;Frontiers in Immunology;2024-01-15